The Brilacidin-OM clinical trial will be, as clini
Post# of 72440
(Total Views: 367)
Posted On: 04/26/2019 1:42:02 PM
The Brilacidin-OM clinical trial will be, as clinical trials go, inexpensive.
The Bril-ABSSSI clinical trial was estimated to cost about 30 million because of the very long time it would take to recruit clinical trial participants in a very large number of sites, the high costs of IV administration in a hospital, and the difficulty of assessing what would be a "success" in a population with severe infections that could takes months to resolve.
As a contrast, Bril-OM will be cheap to administer (powdered-form sachets, mixed and used by the patient) and results will be available quite quickly -- a matter of a couple months at the most to see if OM develops and if so, how severe it is.
Estimates of 50-100 million for a clinical trial of any of IPIX's drugs are completely out of the ballpark. No evidence of those kinds of costs.
The Bril-ABSSSI clinical trial was estimated to cost about 30 million because of the very long time it would take to recruit clinical trial participants in a very large number of sites, the high costs of IV administration in a hospital, and the difficulty of assessing what would be a "success" in a population with severe infections that could takes months to resolve.
As a contrast, Bril-OM will be cheap to administer (powdered-form sachets, mixed and used by the patient) and results will be available quite quickly -- a matter of a couple months at the most to see if OM develops and if so, how severe it is.
Estimates of 50-100 million for a clinical trial of any of IPIX's drugs are completely out of the ballpark. No evidence of those kinds of costs.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼